Application Deadline U.S. citizens: 2025-26 Fulbright U.S. Scholar Competition Deadline is Monday, September 16, 2024 at 5 PM EST. Find out more.
Home Country United Kingdom Cancer Research: Inhibition of C-erb B-2 Transcriptional Control in Human Breast Carcinoma Using Gene-Specific Triple Helix Oligodeoxynucleotides Program Fulbright Visiting Scholar Program Program Country United Kingdom Grant Activity Type Research Discipline Medical Sciences Academic Year 1993-1994 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title Cancer Research: Inhibition of C-erb B-2 Transcriptional Control in Human Breast Carcinoma Using Gene-Specific Triple Helix Oligodeoxynucleotides Scholar Information Grantee Donal Hollywood Title Clinical Research Fellow Institution Hammersmith Hospital Department ICRF Oncology Group Host Institutions Institution Baylor College of Medicine Faculty Dr. Michael Hogan Host Department Center for Biotechnology Institution Baylor College of Medicine Faculty Dr. Michael Hogan Host Department Center for Biotechnology
Cancer Research: Inhibition of C-erb B-2 Transcriptional Control in Human Breast Carcinoma Using Gene-Specific Triple Helix Oligodeoxynucleotides Program Fulbright Visiting Scholar Program Program Country United Kingdom Grant Activity Type Research Discipline Medical Sciences Academic Year 1993-1994 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title Cancer Research: Inhibition of C-erb B-2 Transcriptional Control in Human Breast Carcinoma Using Gene-Specific Triple Helix Oligodeoxynucleotides Scholar Information Grantee Donal Hollywood Title Clinical Research Fellow Institution Hammersmith Hospital Department ICRF Oncology Group Host Institutions Institution Baylor College of Medicine Faculty Dr. Michael Hogan Host Department Center for Biotechnology Institution Baylor College of Medicine Faculty Dr. Michael Hogan Host Department Center for Biotechnology